(Q73540117)

English

Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice

scientific article published on 01 March 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

7

object named as

Fenaux P

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Vantelon JM

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Koscielny S

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Brault P

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Bourhis JH

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Ribrag V

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Pico J

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Munck JN

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

495-499

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713625%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702201

0 references

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage therapy with methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI) for recurrent or refractory lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702201

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73540117&oldid=2087779957"